This finding contradicts a recent report demonstrating an association between elevated ACPA levels and increased risk for acute coronary syndrome in a large (n = 2814) RA cohort, and may be a statistical power issue related to the low frequency of ACPA in PAROKRANK (7.5%) compared to the RA cohort (65%). The gene discussed is PRTN3; the disease is rheumatoid arthritis.